1. Azari, J., Brumbaugh, P., and Huxtable, R.J. 1980, Prophylaxis by taurine in the hearts of cardiomyopathic hamsters, J.Mol.Cell.Cardiol. 12:1353–1366.
2. Azuma, J., Hasagawa, H., Awata, N., Sawamura, A., Harada, H., Ogura, K., Ohta, H., Yamauchi, K., and Kishimoto, S. 1983, Taurine for treatment of congestive heart failure in humans, in: “Sulfur Amino Acids: Biochemical and Clinical Aspects”, Kuriyama, K., Huxtable, R.J. and Iwata, H. eds., A. R. Liss, New York, pp. 61–72.
3. Azuma, J., Sawamura, A., Awata, N., Ohta, H., Hamaguchi, T., Harada, H., Takihara, K., Hasegawa, H., Yamagami, T., Ishiyama, T., Iwata, H., and Kishimoto, S. 1985, Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial, Clin.Cardiol. 8:276–282.
4. Azuma, J., Takahisa, K., Awata, N., Ohta, H., Sawamura, A., Harada, H., and Kishimoto, S. 1984, Beneficial effect of taurine on congestive heart failure induced by chronic aortic regurgitation in rabbits, Res.Comm.Chem.Pathol.Pharmacol. 45:261–270.
5. Banks, M.A., Porter, D.W., Martin, W.G., and Castranova, V. 1991, Ozone-induced lipid peroxidation and membrane leakage in isolated rat alveolar macrophages: Protective effects of taurine, J.Nutr.Biochem. 2:308–313.